DE3810874A1 - Substituierte 1,3-dioxolan- und 1,3-dioxan-derivate, verfahren zu ihrer herstellung und ihre verwendung - Google Patents

Substituierte 1,3-dioxolan- und 1,3-dioxan-derivate, verfahren zu ihrer herstellung und ihre verwendung

Info

Publication number
DE3810874A1
DE3810874A1 DE3810874A DE3810874A DE3810874A1 DE 3810874 A1 DE3810874 A1 DE 3810874A1 DE 3810874 A DE3810874 A DE 3810874A DE 3810874 A DE3810874 A DE 3810874A DE 3810874 A1 DE3810874 A1 DE 3810874A1
Authority
DE
Germany
Prior art keywords
tolyl
dioxolane
compound
formula
butyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
DE3810874A
Other languages
German (de)
English (en)
Inventor
Jeffrey Nadelson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sandoz AG
Sandoz Patent GmbH
Original Assignee
Sandoz AG
Sandoz Patent GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz AG, Sandoz Patent GmbH filed Critical Sandoz AG
Publication of DE3810874A1 publication Critical patent/DE3810874A1/de
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D319/00—Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D319/04—1,3-Dioxanes; Hydrogenated 1,3-dioxanes
    • C07D319/06—1,3-Dioxanes; Hydrogenated 1,3-dioxanes not condensed with other rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/10—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings
    • C07D317/12—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to ring carbon atoms

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Diabetes (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Obesity (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Emergency Medicine (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
  • Medicinal Preparation (AREA)
DE3810874A 1987-04-01 1988-03-30 Substituierte 1,3-dioxolan- und 1,3-dioxan-derivate, verfahren zu ihrer herstellung und ihre verwendung Withdrawn DE3810874A1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US3411887A 1987-04-01 1987-04-01

Publications (1)

Publication Number Publication Date
DE3810874A1 true DE3810874A1 (de) 1988-10-20

Family

ID=21874422

Family Applications (1)

Application Number Title Priority Date Filing Date
DE3810874A Withdrawn DE3810874A1 (de) 1987-04-01 1988-03-30 Substituierte 1,3-dioxolan- und 1,3-dioxan-derivate, verfahren zu ihrer herstellung und ihre verwendung

Country Status (18)

Country Link
JP (1) JPS63277672A (el)
KR (1) KR880012224A (el)
AU (1) AU1400788A (el)
BE (1) BE1000783A3 (el)
DE (1) DE3810874A1 (el)
DK (1) DK179288A (el)
ES (1) ES2011831A6 (el)
FR (1) FR2613226B1 (el)
GB (1) GB2202849A (el)
GR (1) GR880100196A (el)
HU (1) HUT50156A (el)
IL (1) IL85920A0 (el)
IT (1) IT1219895B (el)
LU (1) LU87176A1 (el)
NL (1) NL8800805A (el)
PT (1) PT87127B (el)
SE (1) SE8801166L (el)
ZA (1) ZA882350B (el)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8701961D0 (en) * 1987-01-29 1987-03-04 Unilever Plc Perfumery materials

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3235589A1 (de) * 1982-09-25 1984-03-29 Hoechst Ag, 6230 Frankfurt Benzylether von phenol-mannich-basen, verfahren zu ihrer herstellung, ihre verwendung sowie pharmazeutische praeparate auf basis dieser verbindungen, zwischenprodukte und verfahren zu deren herstellung

Also Published As

Publication number Publication date
IT8847797A0 (it) 1988-03-30
FR2613226A1 (fr) 1988-10-07
GR880100196A (el) 1989-01-31
BE1000783A3 (fr) 1989-04-04
AU1400788A (en) 1988-10-06
SE8801166L (sv) 1988-10-02
DK179288D0 (da) 1988-03-30
LU87176A1 (fr) 1988-11-17
IT1219895B (it) 1990-05-24
SE8801166D0 (sv) 1988-03-29
PT87127A (pt) 1988-04-01
FR2613226B1 (fr) 1989-09-15
ES2011831A6 (es) 1990-02-16
HUT50156A (en) 1989-12-28
KR880012224A (ko) 1988-11-26
PT87127B (pt) 1992-07-31
DK179288A (da) 1988-10-02
IL85920A0 (en) 1988-09-30
ZA882350B (en) 1989-12-27
NL8800805A (nl) 1988-11-01
GB8807503D0 (en) 1988-05-05
GB2202849A (en) 1988-10-05
JPS63277672A (ja) 1988-11-15

Similar Documents

Publication Publication Date Title
CH638802A5 (de) Verfahren zur herstellung neuer 4-amino-4-arylcyclohexanonverbindungen.
DE2839884C2 (de) Hydroxyalkyl-bzw. oxoalkyl-substituierte Phenole und diese enthaltende Arzneimittel
CH630364A5 (de) Verfahren zur herstellung von neuen aminoalkylheterocyclen und ihren saeureadditionssalzen.
DE2951675A1 (de) Neue guanidinothiazolverbindungen, verfahren zu deren herstellung und arzneimittelzubereitungen
DE2516554A1 (de) Thienyl- und thiaethylverbindungen
EP0529500B1 (de) Arzneimittel zur Behandlung von Abstossungsreaktionen bei Organverpflanzungen
DE2160148C2 (de) Arzneimittel und bestimmte Sulfoxide als solche
DE2415697A1 (de) Alkylphenylbenzopyrane
DE69005861T2 (de) Benzoxepin-Derivate.
DE2609210A1 (de) Substituierte piperazinyliminorifamycine, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
DE3810874A1 (de) Substituierte 1,3-dioxolan- und 1,3-dioxan-derivate, verfahren zu ihrer herstellung und ihre verwendung
DE2819372C2 (el)
DE2822751A1 (de) Cyclopentanderivate, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzungen
EP0539806A1 (de) Thiadiazinone und sie enthaltende Arzneimittel, insbesondere mit Positiv-Inotroper und vasodilatierender Wirksamkeit
DE3429227A1 (de) 1,3-dioxanderivate, verfahren zu ihrer herstellung und diese enthaltende arzneimittel
DE69203194T2 (de) Thiazolidine-2,4-dione für die Behandlung der Hypertonie.
DE2647966A1 (de) Derivate des 4-(6'-methoxy-2'- naphthyl)-butan-2-ons, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
EP0313935A2 (de) Enolether von 6-Chlor-4-hydroxy-2-methyl-N-(2-pyridyl)-2H-thieno(2,3-e)-1,2-thiazin-3-carbonsäureamid-1,1-dioxid, ein Verfahren zu ihrer Herstellung sowie ihre Verwendung
EP0030343A1 (de) Substituierte 2-Amino-3,4-dihydropyridinderivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
DE3012190A1 (de) Pharmazeutisches mittel auf der basis 1,3,5-substituierter biuret-verbindungen
DE1947226C3 (de) 1 l-Chlor-8,12b-dihydro-23-dimethyll2b-phenyl-4H [13] -oxazino [3,2-d] [1,4] benzodiazepin-4,7(6H)dion und Verfahren zur Herstellung dieser Verbindung
DE10138538C2 (de) Tumorhemmende Lanthanverbindungen
DE3205457A1 (de) Oxazolidin-2-one
DE69018741T2 (de) Konjugierte gamma-Hydroxybutenolid-Derivate und sie als aktiver Wirkstoff enthaltende Mittel gegen Magengeschwüre.
DE2628642C2 (de) In 2-Stellung substituierte 1,3-Diaza-fünfringkohlenstoffverbindungen, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Mittel

Legal Events

Date Code Title Description
8139 Disposal/non-payment of the annual fee